Seufert J - Search Results

1

Insulin modulates the inflammatory granulocyte response to streptococci via phosphatidylinositol 3-kinase.

Kenzel S, Mergen M, von Süßkind-Schwendi J, Wennekamp J, Deshmukh SD, Haeffner M, Triantafyllopoulou A, Fuchs S, Farmand S, Santos-Sierra S, Seufert J, van den Berg TK, Kuijpers TW, Henneke P. Kenzel S, et al. Among authors: seufert j. J Immunol. 2012 Nov 1;189(9):4582-91. doi: 10.4049/jimmunol.1200205. Epub 2012 Sep 26. J Immunol. 2012. PMID: 23018458 Free PMC article.

2

NUPR1 preserves insulin secretion of pancreatic β-cells during inflammatory stress by multiple low-dose streptozotocin and high-fat diet.

Päth G, Mehana AE, Pilz IH, Alt M, Baumann J, Sommerer I, Hoffmeister A, Seufert J. Päth G, et al. Among authors: seufert j. Am J Physiol Endocrinol Metab. 2020 Aug 1;319(2):E338-E344. doi: 10.1152/ajpendo.00088.2020. Epub 2020 Jun 23. Am J Physiol Endocrinol Metab. 2020. PMID: 32574111 Free PMC article.

3

Mesenchymal stem cell (MSC)-mediated survival of insulin producing pancreatic β-cells during cellular stress involves signalling via Akt and ERK1/2.

Liu C, Zhang W, Peradze N, Lang L, Straetener J, Feilen PJ, Alt M, Jäger C, Laubner K, Perakakis N, Seufert J, Päth G. Liu C, et al. Among authors: seufert j. Mol Cell Endocrinol. 2018 Sep 15;473:235-244. doi: 10.1016/j.mce.2018.01.024. Epub 2018 Feb 5. Mol Cell Endocrinol. 2018. PMID: 29421520

4

Protein phosphatase 1 (PP-1)-dependent inhibition of insulin secretion by leptin in INS-1 pancreatic β-cells and human pancreatic islets.

Kuehnen P, Laubner K, Raile K, Schöfl C, Jakob F, Pilz I, Päth G, Seufert J. Kuehnen P, et al. Among authors: seufert j. Endocrinology. 2011 May;152(5):1800-8. doi: 10.1210/en.2010-1094. Epub 2011 Mar 22. Endocrinology. 2011. PMID: 21427225

5

Human Krüppel-like factor 11 differentially regulates human insulin promoter activity in β-cells and non-β-cells via p300 and PDX1 through the regulatory sites A3 and CACCC box.

Perakakis N, Danassi D, Alt M, Tsaroucha E, Mehana AE, Rimmer N, Laubner K, Wang H, Wollheim CB, Seufert J, Päth G. Perakakis N, et al. Among authors: seufert j. Mol Cell Endocrinol. 2012 Nov 5;363(1-2):20-6. doi: 10.1016/j.mce.2012.07.003. Epub 2012 Jul 16. Mol Cell Endocrinol. 2012. PMID: 22801105

6

PDX1- and NGN3-mediated in vitro reprogramming of human bone marrow-derived mesenchymal stromal cells into pancreatic endocrine lineages.

Limbert C, Päth G, Ebert R, Rothhammer V, Kassem M, Jakob F, Seufert J. Limbert C, et al. Among authors: seufert j. Cytotherapy. 2011 Aug;13(7):802-13. doi: 10.3109/14653249.2011.571248. Epub 2011 Apr 21. Cytotherapy. 2011. PMID: 21506889

7

Glucose-dependent expansion of pancreatic beta-cells by the protein p8 in vitro and in vivo.

Päth G, Opel A, Gehlen M, Rothhammer V, Niu X, Limbert C, Romfeld L, Hügl S, Knoll A, Brendel MD, Bretzel RG, Seufert J. Päth G, et al. Among authors: seufert j. Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1168-76. doi: 10.1152/ajpendo.00436.2005. Epub 2006 Jul 5. Am J Physiol Endocrinol Metab. 2006. PMID: 16822955 Free article.

8

Carbohydrate intake and insulin requirement in children, adolescents and young adults with cystic fibrosis-related diabetes: A multicenter comparison to type 1 diabetes.

Scheuing N, Thon A, Konrad K, Bauer M, Karsten C, Meissner T, Seufert J, Schönau E, Schöfl C, Woelfle J, Holl RW; German/Austrian Diabetes Prospective Documentation Initiative and the BMBF Competence Network Diabetes Mellitus. Scheuing N, et al. Among authors: seufert j. Clin Nutr. 2015 Aug;34(4):732-8. doi: 10.1016/j.clnu.2014.08.016. Epub 2014 Sep 15. Clin Nutr. 2015. PMID: 25245859

9

DJ-1 Protects Pancreatic Beta Cells from Cytokine- and Streptozotocin-Mediated Cell Death.

Jain D, Weber G, Eberhard D, Mehana AE, Eglinger J, Welters A, Bartosinska B, Jeruschke K, Weiss J, Päth G, Ariga H, Seufert J, Lammert E. Jain D, et al. Among authors: seufert j. PLoS One. 2015 Sep 30;10(9):e0138535. doi: 10.1371/journal.pone.0138535. eCollection 2015. PLoS One. 2015. PMID: 26422139 Free PMC article.

10

Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study.

Seufert J, Pegelow K, Bramlage P. Seufert J, et al. Vasc Health Risk Manag. 2013;9:711-7. doi: 10.2147/VHRM.S54362. Epub 2013 Nov 13. Vasc Health Risk Manag. 2013. PMID: 24259985 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page